The cataract surgery devices and equipment market has seen considerable growth due to a variety of factors.
• In the past few years, the market size of cataract surgery devices and equipment has witnessed robust growth. The market which was valued at $14.94 billion in 2024 is predicted to expand to $15.88 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.3%.
Factors such as a growing aging population, rising cataract cases, heightened patient awareness, supportive government policies towards vision care, and escalating healthcare expenditure have mainly fueled this growth in the historic period.
The cataract surgery devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the cataract surgery devices and equipment market is projected to experience consistent expansion, reaching a value of $18.15 billion by 2029 at a compound annual growth rate of 3.4%.
The projected expansion over this period can be attributed to increasing emphasis on outpatient surgery, personalized intraocular lenses, value-driven healthcare models, worldwide vision care initiatives, and global efforts towards eye health. Key trends expected during this forecast period encompass the incorporation of artificial intelligence, teleophthalmology and remote consultations, rapid technological advancements, progress in intraocular lens technology, and technological enhancements in surgical methodologies, such as femtosecond laser technology.
Anticipated growth in the cataract surgery devices and equipment market is primarily linked to the increasing geriatric population. Anyone aged 65 or above falls into this demographic, which is witnessing a surge in cataract cases due to aging, naturally bolstering demand for related surgical equipment and procedures. It follows that an expanding elderly population translates into a greater call for cataract surgeries and subsequent devices. As an example, Population Reference Bureau (PRB), a non-profit organization in the US, predicted in January 2024 that the American population who are aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, a remarkable 47% increase. Furthermore, this demographic is expected to account for 23% of the total population, up from 17%. This data underscores the significant aging trend within the US population and the consequential necessity to cater to the requirements of this older demographic across various realms. Hence, the expanding elderly population is indeed fuelling the growth of the cataract surgery devices and equipment market.
The cataract surgery devices and equipment market covered in this report is segmented –
1) By Type: Intraocular Lens (IOL), Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment, Femtosecond Laser Equipment
2) By Surgery Type: Extracapsular Cataract Extraction, Phacoemulsification, Femtosecond Laser, Other Surgery Types
3) By Application: Ophthalmology Centers, Hospitals, Clinics
Subsegments:
1) By Intraocular Lens (IOL): Monofocal IOL, Multifocal IOL, Toric IOL, Accommodative IOL
2) By Ophthalmic Viscoelastic Device (OVD): Dispersive OVD, Cohesive OVD
3) By Phacoemulsification Equipment: Phacoemulsification Machines, Handpieces And Accessories
4) By Femtosecond Laser Equipment: Femtosecond Laser Systems For Cataract Surgery, Laser Treatment Accessories
Leading firms in the cataract surgery devices and equipment sector are pushing the technological boundaries with the development of innovative products such as the VERITAS Vision System to elevate surgical precision and patient results. The VERITAS Vision System serves as an advanced phacoemulsification platform designed keeping patient safety, surgical efficiency, and comfort in mind. For example, Johnson & Johnson, a pharmaceutical, biotech, and medical tech giant based in the U.S., launched the Tecnis PureSee intraocular lens (IOL) in February 2024. The groundbreaking refractive design of the TECNIS PureSee IOL ensures consistent, premium vision, spectacular contrast, and superb low-light performance that can compete with monofocal IOLs. Cataract surgeries are the most performed surgical procedures globally, with an estimate of 28 million operations annually. Nevertheless, only about 10-15% of patients undergo the installations of advanced optical IOLs specifically meant for astigmatism and presbyopia. Presently, surgeons and their patients often have to compromise when choosing an IOL, weighing between clear vision at all distances and the risk of glares or halos. The TECNIS PureSee effectively addresses these conflicts, thus improving outcomes for both patients and surgeons.
Major companies operating in the cataract surgery devices and equipment market include:
• Johnson & Johnson Services Inc.
• Allergan Inc.
• PhysIOL S.A
• Novartis AG
• Abbott Laboratories
• Alcon Inc.
• HOYA Corporation
• Bausch & Lomb Inc.
• Carl Zeiss Meditech AG
• Topcon Corporation
• NIDEK Co. Ltd.
• Aurolab Co.
• OPHTEC BV
• DORC International BV
• Calhoun Vision Inc.
• Coburn Technologies Inc.
• HumanOptics AG
• Hanita Lenses Ltd.
• Lenstec Inc.
• CRISTALENS SL
• EyeKon Medical Inc.
• ROWIAK GmbH
• Ziemer Ophthalmic Systems AG
• HAAG-Streit Holding AG
• Sonomed Escalon Corp.
• Ellex Medical Lasers Limited
North America was the largest region in the global cataract surgery devices and equipment market in 2024. Asia-Pacific was the second-largest region in cataract surgery devices and equipment market. The regions covered in the cataract surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.